The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Boedtcher-hansen, Mads
    Born in July 1968
    Individual (1 offspring)
    Officer
    2011-09-30 ~ now
    OF - Director → CIF 0
    Mr Mads Boedtcher-hansen
    Born in July 1968
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more as a member of a firm → CIF 0
    PE - Ownership of voting rights - 75% or more as a member of a firm → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 2
  • 1
    Cowdry, John Jeremy Arthur
    Company Director/Solicitor born in July 1944
    Individual (19 offsprings)
    Officer
    2011-09-30 ~ 2011-09-30
    OF - Director → CIF 0
  • 2
    The Old Exchange, 12 Compton Road, Wimbledon, London, United Kingdom
    Active Corporate (2 parents, 190 offsprings)
    Equity (Company account)
    2 GBP2024-01-31
    Officer
    2011-09-30 ~ 2011-09-30
    PE - Secretary → CIF 0
parent relation
Company in focus

NATUPHARMA UK LIMITED

Standard Industrial Classification
46390 - Non-specialised Wholesale Of Food, Beverages And Tobacco
Brief company account
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Class 2 ordinary share
12023-01-01 ~ 2023-12-31
Turnover/Revenue
187,128 GBP2023-01-01 ~ 2023-12-31
142,673 GBP2022-01-01 ~ 2022-12-31
Cost of Sales
81,350 GBP2023-01-01 ~ 2023-12-31
80,699 GBP2022-01-01 ~ 2022-12-31
Gross Profit/Loss
105,778 GBP2023-01-01 ~ 2023-12-31
61,974 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
181,317 GBP2023-01-01 ~ 2023-12-31
167,192 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
-75,539 GBP2023-01-01 ~ 2023-12-31
-105,218 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
364 GBP2023-01-01 ~ 2023-12-31
599 GBP2022-01-01 ~ 2022-12-31
Interest Payable/Similar Charges (Finance Costs)
6,761 GBP2023-01-01 ~ 2023-12-31
98 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
-81,936 GBP2023-01-01 ~ 2023-12-31
-104,717 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-81,936 GBP2023-01-01 ~ 2023-12-31
-104,717 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
-81,936 GBP2023-01-01 ~ 2023-12-31
-104,717 GBP2022-01-01 ~ 2022-12-31
Total Inventories
14,718 GBP2023-12-31
21,563 GBP2022-12-31
Debtors
72,915 GBP2023-12-31
21,624 GBP2022-12-31
Cash at bank and in hand
75,072 GBP2023-12-31
58,547 GBP2022-12-31
Current Assets
162,705 GBP2023-12-31
101,734 GBP2022-12-31
Creditors
Current
1,503,766 GBP2023-12-31
1,360,859 GBP2022-12-31
Net Current Assets/Liabilities
-1,341,061 GBP2023-12-31
-1,259,125 GBP2022-12-31
Total Assets Less Current Liabilities
-1,341,061 GBP2023-12-31
-1,259,125 GBP2022-12-31
Equity
Called up share capital
100 GBP2023-12-31
100 GBP2022-12-31
100 GBP2021-12-31
Retained earnings (accumulated losses)
-1,341,161 GBP2023-12-31
-1,259,225 GBP2022-12-31
-1,154,508 GBP2021-12-31
Equity
-1,341,061 GBP2023-12-31
-1,259,125 GBP2022-12-31
-1,154,408 GBP2021-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-81,936 GBP2023-01-01 ~ 2023-12-31
-104,717 GBP2022-01-01 ~ 2022-12-31
Wages/Salaries
90,000 GBP2023-01-01 ~ 2023-12-31
85,000 GBP2022-01-01 ~ 2022-12-31
Social Security Costs
6,165 GBP2023-01-01 ~ 2023-12-31
10,964 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
96,165 GBP2023-01-01 ~ 2023-12-31
95,964 GBP2022-01-01 ~ 2022-12-31
Average Number of Employees
12023-01-01 ~ 2023-12-31
12022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
55,005 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
55,005 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
69,577 GBP2023-12-31
9,777 GBP2022-12-31
Other Debtors
Current
1,571 GBP2023-12-31
11,847 GBP2022-12-31
Amount of value-added tax that is recoverable
Current
1,767 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
72,915 GBP2023-12-31
21,624 GBP2022-12-31
Trade Creditors/Trade Payables
Current
435,786 GBP2023-12-31
376 GBP2022-12-31
Amounts owed to group undertakings
Current
1,056,681 GBP2023-12-31
1,349,072 GBP2022-12-31
Other Taxation & Social Security Payable
Current
9,197 GBP2023-12-31
5,866 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
2,102 GBP2023-12-31
3,205 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
90 shares2023-12-31
Class 2 ordinary share
10 shares2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
-81,936 GBP2023-01-01 ~ 2023-12-31
  • NATUPHARMA UK LIMITED
    Info
    Registered number 07793447
    Minerva Mill Innovation Centre Office 29, Ground Floor, Station Road, Alcester, Warwickshire B49 5ET
    Private Limited Company incorporated on 2011-09-30 (13 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.